Cardiothoracic Surgery

Nominations are due Friday, October 27, for the Extraordinary Women in Cardiothoracic Surgery Award. Nominate an exemplary clinician and surgeon, leader, educator, mentor, advocate. STS and Women in Thoracic Surgery (WTS) will honor recipients at a special awards breakfast during STS 2024 in January. Learn more: bit.ly/46hV0wq

Do NOT miss the ELSO neonatal & pediatric virtual training course:
🖥 self-paced course (25 recorded online lectures) to allow practitioners to develop, strengthen, refine clinical skills related to ECMO care and improve confidence in working with children on an ECMO circuit.
🖥 live case study series + Q&A session with select members of the course faculty, moderated by Giles Peek on November 6, 2023
🔗 bit.ly/ELSOAcademy
Completion of the course will comply with Step 1 requirements for the ELSO - Neonatal & Pediatrics ECMO Certification Exam (E-NPEC), designed to reflect a global standard in foundational ECMO education for neonatal & pediatric practitioners!
🎯 Target audience: the entire team! physicians, nurses, perfusionists, respiratory therapists... CME: Available upon completion.
📬 Need additional information? email [email protected]

https://www.tctmd.com/news/surgeons-support-proposed-changes-left-main-cad-guidelines

Surgeons Support Proposed Changes to Left Main CAD Guidelines The controversy over the guidelines has lost steam with the newly proposed downgrade for PCI, says one surgeon.

https://www.sts.org/2024-extraordinary-women-cardiothoracic-surgery-award?_cldee=ldC5fpKYE6YfD-w3W43tU5XvpqglHDdn9DkySOKaboZRNp3REpUJv2fM_p3npfsM&recipientid=contact-dccd0591fb5ae511a0e8f4ce4686c194-0ea03c8ad53f4e30a61959c3c95f5d66&esid=ee38fe8a-2e57-ee11-be6e-6045bdd7307d

Nominations being sought for the 2024 STS Extraordinary Women in Cardiothoracic Surgery Award

2024 Extraordinary Women in Cardiothoracic Surgery Award | STS Image Nominations

https://pubmed.ncbi.nlm.nih.gov/36040710/

A nice review on outcomes with the Cox Maze vs Pulmonary Vein Isolation for atrial fibrillation with concomitant mitral valve surgery by Davorin Sef

From the conclusion: "Concomitant Cox-Maze in AF patients undergoing MV surgery is associated with better mid-term freedom from AF when compared to PVI with comparable mid-term survival."

Comparing mid-term outcomes of Cox-Maze procedure and pulmonary vein isolation for atrial fibrillation after concomitant mitral valve surgery: A systematic review - PubMed Concomitant Cox-Maze in AF patients undergoing MV surgery is associated with better mid-term freedom from AF when compared to PVI with comparable mid-term survival. Large observational studies suggest that there might be a mid-term survival benefit among patients after concomitant Cox-Maze. Further....

"Colchicine does not significantly reduce perioperative atrial fibrillation (AF) or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery"

Colchicine does not reduce perioperative AF or MINS in major non-cardiac thoracic surgery Colchicine does not significantly reduce perioperative atrial fibrillation (AF) or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

https://www.ahajournals.org/doi/full/10.1161/JAHA.123.029553

Although likely inferred already by structural heart teams, more concrete data showing that patients with low flow, low gradient aortic stenosis who present with mitral regurgitation have worse outcomes.

Prognostic Impact of Mitral Regurgitation Before and After Transcatheter Aortic Valve Replacement in Patients With Severe Low‐Flow, Low‐Gradient Aortic Stenosis Background There is little evidence about the prognostic role of mitral regurgitation (MR) in patients with low‐flow, low‐gradient aortic stenosis undergoing transcatheter aortic valve replacement ...

Study out of UNC on lung transplant outcomes in patients who had COVID-19 related lung disease.

"Among 195 patients with COVID-19-related acute respiratory distress syndrome (ARDS) who underwent lung transplants, 1-, 6-, and 12-month overall survival rates were 99%, 95%, and 88%. For 190 patients who had COVID-19-related pulmonary fibrosis, survival rates were 96%, 92%, and 84%, respectively."
-Medpage Today

Outcomes Following Lung Transplant for COVID-19–Related Complications in the US This cohort study evaluates overall survival and graft failure rates following lung transplant among patients with irreversible lung injury.

https://cardiovascularbusiness.com/topics/clinical/structural-heart-disease/abbott-pulls-trifecta-heart-valves-market-due-early-deterioration

Abbott pulls Trifecta heart valves off the market due to early deterioration The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years.

🚨 in thoracic emergencies, narrative review of current evidence:
📄 description & classification of thoracic emergencies
🫁 mediastinal mass
🫁 tracheobronchial emergencies
🫁 chest trauma & parenchymal injuries
🩸 thoracic penetrating injuries & hemorrhagic shock
🩸 aortic injuries
🫁 blunt thoracic trauma
🫀 cardiac trauma & traumatic cardiac arrest
💣 combat injuries
🔥 burn injuries
✅ benefits of in patients
‼️ limitations of ECLS in trauma patients
Free open access
🖇️ https://jtd.amegroups.org/article/view/74016/html